Clinical trial
Correlations Between Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma
NCT04664413 is registered in ClinicalTrials.gov with University of Salerno as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Correlations Between Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma
- Lead sponsor
- University of Salerno
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2021
- Completion date
- May 30, 2021
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
papillary thyroid cancer